Skip to main content

Danaher Value Stock - Dividend - Research Selection

Danaher

ISIN: US2358511028 , WKN: 866197

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company\'s Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians\' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Some Investors May Be Willing To Look Past Danaher's (NYSE:DHR) Soft Earnings

2025-10-28
Danaher Corporation's ( NYSE:DHR ) stock was strong despite it releasing a soft earnings report last week. Our analysis...

5 Must-Read Analyst Questions From Danaher’s Q3 Earnings Call

2025-10-28
Danaher’s third quarter was marked by solid execution across its core businesses, with management citing bioprocessing momentum and a stronger-than-anticipated performance in respiratory diagnostics as key drivers. CEO Rainer Blair highlighted that demand for monoclonal antibody production remained robust, propelling bioprocessing growth, while Cepheid’s respiratory testing revenues benefited from customers ordering earlier than usual. Management also pointed to disciplined cost management and o

Unlocking Danaher (DHR) International Revenues: Trends, Surprises, and Prospects

2025-10-27
Explore Danaher's (DHR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

This Week In Markets: Earnings, Inflation, And Geopolitical Shifts

2025-10-25
Corporate earnings were the primary market driver this week, fueling sector-specific rallies and helping equities reclaim record levels.

Dividend Champion, Contender, And Challenger Highlights: Week Of October 26

2025-10-24
Get the latest weekly summary on Dividend Champions, Contenders & Challengers. Track dividend changes, upcoming ex-dividend and pay dates.

DHR Q3 2025 Deep Dive: Bioprocessing, Diagnostics, and Productivity Initiatives Amid Policy Shifts

2025-10-24
Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.4% year on year to $6.05 billion. On the other hand, next quarter’s revenue guidance of $6.70 billion was less impressive, coming in 4.7% below analysts’ estimates. Its non-GAAP profit of $1.89 per share was 9.8% above analysts’ consensus estimates.

Wells Fargo Maintains Danaher (DHR) Equal-Weight Recommendation

2025-10-23

Jim Cramer Says “Danaher Gave Us the Quarter We’ve Been Looking For”

2025-10-23
Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer recently highlighted. Discussing the post-earnings rally of the stock, Cramer remarked: “Then there’s Danaher, DHR, the life sciences and diagnostic equipment company, which has been a huge disappointment for my Charitable Trust for so long. Not today, though. Today, Danaher gave us the quarter we’ve […]

Cell Culture Media Storage Containers Market Report 2025, with Profiles of Avantor, BD Biosciences, Celltreat Scientific Products, Corning, Danaher, DWK Life Sciences, Eppendorf, Euroclone, and More

2025-10-23
The demand for Cell Culture Media Storage Containers is rising due to biopharma growth, regenerative medicine, and eco-friendly trends. Opportunities lie in advanced, sustainable storage solutions, single-use systems, and automation for improved compliance and efficiency, driven by stricter GMP standards and bioprocessing needs. Cell Culture Media Storage Containers Market Cell Culture Media Storage Containers Market Dublin, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The "Cell Culture Media Storage Conta

Danaher (DHR) Margin Declines to 14.4%, Challenging Bullish Growth Narratives

2025-10-23
Danaher (DHR) reported net profit margins of 14.4%, down from 16.6% a year ago, while earnings have declined at an average annual rate of 5.6% over the past five years. Despite this pullback, analysts expect Danaher's earnings to grow 16.72% annually, which is ahead of the broader US market’s projected 15.5% yearly growth. However, revenue growth forecasts lag at 5.2% per year compared to the market’s 10%. With no major or minor risks flagged in the current data, investors are weighing the...